Intelligent Bio Solutions【INBS】銘柄情報

Intelligent Bio Solutions Inc (INBS) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

2.12

( -2.30% )

買値

2.15

売値

2.20

出来高

22,656

平均取引量 (3 か月)

US$ 104,889

財務取引量

US$ 49,815

2.14 日の範囲 2.28

0.538 52 週間の範囲 24.90

時価総額

5.071M

企業価値

133.706k

前日終値

2.17

始値

2.18

時刻

325

2.12

(formt)

最終取引時間

07:12:14

VWAP

2.1988

歳入

3.91M

純利益

-11.61M

発行済株式数

2,391,846

浮動株比率 (%)

90.78%

機関投資家保有比率 (%)

9.98%

配当利回り

PER

-0.2

株価売上高倍率 (PSR)

1.37

1 株当たり利益 (EPS)

-11.34

ベータ

4.17

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platf... Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

ibs.inc

本社

New York, United States

設立

2026

Intelligent Bio Solutions Inc is listed in the Healthcare sector of the ナスダック市場 with ticker INBS. The last closing price for Intelligent Bio Solutions was US$2.17. Over the last year, Intelligent Bio Solutions shares have traded in a share price range of US$ 0.538 to US$ 24.90.

Intelligent Bio Solutions currently has 2,391,846 shares in issue. The market capitalisation of Intelligent Bio Solutions is US$5.07 million. Intelligent Bio Solutions has a price to earnings ratio (PE ratio) of -0.20.

Form 8-K - Current report

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Interference Study designed to validate system specificity in the presence of potentially interfering...

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the...

Form 8-K - Current report

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerprinting Drug...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Razor-razorblade business model accelerates, with Q3 cartridge revenue up 59% year-over-year, representing 66...

Form 8-K - Current report

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.14	-6.19469026549	2.26	2.32	2.11	24310	2.23037434	CS
4	-0.19	-8.22510822511	2.31	2.46	2.08	35087	2.27637609	CS
12	-0.68	-24.2857142857	2.8	5.2	2.08	109479	3.02698256	CS
26	-13.38	-86.3225806452	15.5	24.9	2.08	171172	8.71656917	CS
52	0.39	22.5433526012	1.73	24.9	0.538	733003	8.38833901	CS
156	-0.73	-25.6140350877	2.85	24.9	0.19	1409910	3.10801315	CS
260	1.6251	328.369367549	0.4949	24.9	0.17	1373654	2.77818222	CS